177 related articles for article (PubMed ID: 21102646)
21. [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers].
Kieć-Wilk B; Klupa T; Dembińska-Kieć A
Przegl Lek; 2010; 67(7):496-501. PubMed ID: 21387764
[TBL] [Abstract][Full Text] [Related]
22. Obesity and liver disease.
Younossi ZM
Clin Liver Dis; 2014 Feb; 18(1):xiii-xiv. PubMed ID: 24274879
[No Abstract] [Full Text] [Related]
23. The epidemiology, pathogenesis and histopathology of fatty liver disease.
Levene AP; Goldin RD
Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological profile of hepatic involvement in type-2 diabetes mellitus and its significance.
Banerjee S; Ghosh US; Dutta S
J Assoc Physicians India; 2008 Aug; 56():593-9. PubMed ID: 19051703
[TBL] [Abstract][Full Text] [Related]
25. Liver disease in patients with diabetes mellitus.
Harrison SA
J Clin Gastroenterol; 2006 Jan; 40(1):68-76. PubMed ID: 16340637
[TBL] [Abstract][Full Text] [Related]
26. The spectrum of nonalcoholic fatty liver disease: from steatosis to nonalcoholic steatohepatitis.
Saadeh S; Younossi ZM
Cleve Clin J Med; 2000 Feb; 67(2):96-7, 101-4. PubMed ID: 10680276
[TBL] [Abstract][Full Text] [Related]
27. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.
Lee BW; Lee YH; Park CY; Rhee EJ; Lee WY; Kim NH; Choi KM; Park KG; Choi YK; Cha BS; Lee DH;
Diabetes Metab J; 2020 Jun; 44(3):382-401. PubMed ID: 32431115
[TBL] [Abstract][Full Text] [Related]
28. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Ferreira VS; Pernambuco RB; Lopes EP; Morais CN; Rodrigues MC; Arruda MJ; Silva LM; Vilar L
Arq Bras Endocrinol Metabol; 2010 Jun; 54(4):362-8. PubMed ID: 20625647
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
Wong VW; Hui AY; Tsang SW; Chan JL; Wong GL; Chan AW; So WY; Cheng AY; Tong PC; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2006 Oct; 24(8):1215-22. PubMed ID: 17014580
[TBL] [Abstract][Full Text] [Related]
30. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease].
Kim MY; Baik SK
Korean J Hepatol; 2008 Mar; 14(1):1-3. PubMed ID: 18367852
[No Abstract] [Full Text] [Related]
31. Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Moh Moh MA; Jung CH; Lee B; Choi D; Kim BY; Kim CH; Kang SK; Mok JO
Diab Vasc Dis Res; 2019 Mar; 16(2):186-195. PubMed ID: 30428692
[TBL] [Abstract][Full Text] [Related]
32. [On the clinical picture of fatty degeneration of the liver and fatty liver].
Teichmann W; Lindemann A
Z Gesamte Inn Med; 1967 Sep; 22(17):509-14. PubMed ID: 5591413
[No Abstract] [Full Text] [Related]
33. [The influence and prevalence of nonalcoholic steatohepatitis in chronic hepatitis B].
Pîrvulescu I; Suciu S; Andrei M; Lupu A; Diculescu M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):91-6. PubMed ID: 21688564
[TBL] [Abstract][Full Text] [Related]
34. The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis.
Buchman AL; Naini BV; Spilker B
Semin Liver Dis; 2017 Feb; 37(1):33-44. PubMed ID: 28201847
[TBL] [Abstract][Full Text] [Related]
35. Frequency of Non-Alcoholic Steatohepatitis on Histopathology in Patients of Type 2 Diabetes Mellitus with Duration of More than 5 Years.
Seetlani NK; Memon AR; Tanveer S; Ali A; Ali P; Imran K; Haroon H
J Coll Physicians Surg Pak; 2016 Aug; 26(8):643-6. PubMed ID: 27539754
[TBL] [Abstract][Full Text] [Related]
36. Review article: Non-alcoholic fatty liver disease.
Alba LM; Lindor K
Aliment Pharmacol Ther; 2003 Apr; 17(8):977-86. PubMed ID: 12694079
[TBL] [Abstract][Full Text] [Related]
37. Nonalcoholic fatty liver disease in lean individuals in the United States.
Younossi ZM; Stepanova M; Negro F; Hallaji S; Younossi Y; Lam B; Srishord M
Medicine (Baltimore); 2012 Nov; 91(6):319-327. PubMed ID: 23117851
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan.
Akuta N; Kawamura Y; Arase Y; Saitoh S; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Suzuki Y; Suzuki F; Ikeda K; Kumada H
BMC Gastroenterol; 2018 Nov; 18(1):165. PubMed ID: 30400829
[TBL] [Abstract][Full Text] [Related]
39. Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations.
Arrese M; Barrera F; Triantafilo N; Arab JP
Expert Rev Gastroenterol Hepatol; 2019 Sep; 13(9):849-866. PubMed ID: 31353974
[No Abstract] [Full Text] [Related]
40. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kobashigawa K; Kinjo F; Saito A
Hepatogastroenterology; 2003; 50(54):2005-8. PubMed ID: 14696453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
